Tekereko?lu M.S.Ayan M.Otlu B.Taştekin N.A?el H.E.Durmaz B.Özerol I.H.2024-08-042024-08-0420010374-9096https://hdl.handle.net/11616/90618One hundred Klebsiella pneumoniae strains isolated from various clinical specimens were investigated for the presence of extended spectrum beta-lactamases (ESBL) and the antimicrobial susceptibility patterns. The ESBL production was detected in 44% of strains isolated from inpatients and 14% of strains isolated from outpatients. The antimicrobial susceptibility rates of the total 100 strains and ESBL positive 58 strains were found to be as follows respectively: Cephalotin and cefuroxime 40% and 0%, cefoxitin 78% and 100%, ceftazidime 48% and 20%, cefotaxime 56% and 20%, ceftriaksone 52% and 18%, gentamicin 66% and 40%, amikacin 70% and 65%, ciprofloxacin 88% and 90%, imipenem 80% and 90%, meropenem 100% and 100%, aztreonam 50% and 30%, amoxicillin-clavulonic acid 28% and 10%, and trimethoprimsulphametoxazole 72% and 40 percent. The results indicated that ciprofloxacin, imipenem and meropenem might be used in the therapy of infections due to K. pneumoniae.trinfo:eu-repo/semantics/closedAccessAntimicrobial susceptibilityExtended spectrum beta-lactamaseKlebsiella pneumoniaeArticle3522252302-s2.0-0034982489Q4